Global Pharmaceuticals, Biotechnology & Life Sciences
Introduction
Global Pharmaceuticals, Biotechnology & Life Sciences industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2006-10, and forecast to 2015). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Global pharmaceuticals, biotechnology & life sciences market. Includes market size and segmentation data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.
Highlights
Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the pharmaceuticals, biotechnology & life sciences market in the global
Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the globalpharmaceuticals, biotechnology & life sciences market
Leading company profiles reveal details of key pharmaceuticals, biotechnology & life sciences market players’ global operations and financial performance
Add weight to presentations and pitches by understanding the future growth prospects of the Global pharmaceuticals, biotechnology & life sciences market with five year forecasts
Identify the most important regions for pharmaceuticals, biotechnology & life sciences, with the global market segmented by geography fpr 2010
Key Questions Answered
What was the size of the Global pharmaceuticals, biotechnology & life sciences market by value in 2010?
What will be the size of the Global pharmaceuticals, biotechnology & life sciences market in 2015?
What factors are affecting the strength of competition in the Global pharmaceuticals, biotechnology & life sciences market?
How has the market performed over the last five years?
Who are the top competitiors in the global's pharmaceuticals, biotechnology & life sciences market?
Global Pharmaceuticals, Biotechnology & Life Sciences industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2006-10, and forecast to 2015). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Global pharmaceuticals, biotechnology & life sciences market. Includes market size and segmentation data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.
Highlights
- The global pharmaceuticals, biotechnology, and life sciences industry group is composed of the pharmaceuticals market, the biotechnology market, and the life sciences tools and services market.
- The global pharmaceuticals, biotechnology, and life sciences industry group generated total revenues of $1,001 billion in 2010, representing a compound annual growth rate (CAGR) of 6.8% for the period spanning 2005-2010.
- Pharmaceuticals proved the most lucrative for the global pharmaceuticals, biotechnology, and life sciences industry group in 2010, generating total revenues of $733.1 billion, equivalent to 73.2% of the industry group's overall value.
- The performance of the industry group is forecast to accelerate, with an anticipated CAGR of 7% for the five-year period 2010-2015, which is expected to drive the market to a value of $1,405 billion by the end of 2015.
Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the pharmaceuticals, biotechnology & life sciences market in the global
Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the globalpharmaceuticals, biotechnology & life sciences market
Leading company profiles reveal details of key pharmaceuticals, biotechnology & life sciences market players’ global operations and financial performance
Add weight to presentations and pitches by understanding the future growth prospects of the Global pharmaceuticals, biotechnology & life sciences market with five year forecasts
Identify the most important regions for pharmaceuticals, biotechnology & life sciences, with the global market segmented by geography fpr 2010
Key Questions Answered
What was the size of the Global pharmaceuticals, biotechnology & life sciences market by value in 2010?
What will be the size of the Global pharmaceuticals, biotechnology & life sciences market in 2015?
What factors are affecting the strength of competition in the Global pharmaceuticals, biotechnology & life sciences market?
How has the market performed over the last five years?
Who are the top competitiors in the global's pharmaceuticals, biotechnology & life sciences market?
Contents
EXECUTIVE SUMMARYMARKET OVERVIEW
Market definition
Research highlights
Market analysis
MARKET VALUE
MARKET SEGMENTATION I
MARKET SEGMENTATION II
MARKET SHARE
FIVE FORCES ANALYSIS
Summary
Buyer power
Supplier power
New entrants
Substitutes
Rivalry
LEADING COMPANIES
Johnson & Johnson
Novartis AG
Pfizer Inc.
F. Hoffmann-La Roche Ltd
MARKET FORECASTS
Market value forecast
APPENDIX
Methodology
Industry associations
Related Datamonitor research
Disclaimer
ABOUT DATAMONITOR
Premium Reports
Summary Reports
Datamonitor consulting
LIST OF TABLES
Table 1: Global pharmaceuticals, biotechnology & life sciences industry value: $ billion, 2006–10
Table 2: Global pharmaceuticals, biotechnology & life sciences industry segmentation I:% share, by value, 2010
Table 3: Global pharmaceuticals, biotechnology & life sciences industry segmentation II: % share, by value, 2010
Table 4: Global pharmaceuticals, biotechnology & life sciences industry share: % share, by value, 2010
Table 5: Johnson & Johnson: key facts
Table 6: Johnson & Johnson: key financials ($)
Table 7: Johnson & Johnson: key financial ratios
Table 8: Novartis AG: key facts
Table 9: Novartis AG: key financials ($)
Table 10: Novartis AG: key financial ratios
Table 11: Pfizer Inc.: key facts
Table 12: Pfizer Inc.: key financials ($)
Table 13: Pfizer Inc.: key financial ratios
Table 14: F. Hoffmann-La Roche Ltd: key facts
Table 15: F. Hoffmann-La Roche Ltd: key financials ($)
Table 16: F. Hoffmann-La Roche Ltd: key financials (CHF)
Table 17: F. Hoffmann-La Roche Ltd: key financial ratios
Table 18: Global pharmaceuticals, biotechnology & life sciences industry value forecast: $ billion, 2010–15
LIST OF FIGURES
Figure 1: Global pharmaceuticals, biotechnology & life sciences industry value: $ billion, 2006–10
Figure 2: Global pharmaceuticals, biotechnology & life sciences industry segmentation I:% share, by value, 2010
Figure 3: Global pharmaceuticals, biotechnology & life sciences industry segmentation II: % share, by value, 2010
Figure 4: Global pharmaceuticals, biotechnology & life sciences industry share: % share, by value, 2010
Figure 5: Forces driving competition in the global pharmaceuticals, biotechnology & life sciences industry, 2010
Figure 6: Drivers of buyer power in the global pharmaceuticals, biotechnology & life sciences industry, 2010
Figure 7: Drivers of supplier power in the global pharmaceuticals, biotechnology & life sciences industry, 2010
Figure 8: Factors influencing the likelihood of new entrants in the global pharmaceuticals, biotechnology & life sciences industry, 2010
Figure 9: Factors influencing the threat of substitutes in the global pharmaceuticals, biotechnology & life sciences industry, 2010
Figure 10: Drivers of degree of rivalry in the global pharmaceuticals, biotechnology & life sciences industry, 2010
Figure 11: Johnson & Johnson: revenues & profitability
Figure 12: Johnson & Johnson: assets & liabilities
Figure 13: Novartis AG: revenues & profitability
Figure 14: Novartis AG: assets & liabilities
Figure 15: Pfizer Inc.: revenues & profitability
Figure 16: Pfizer Inc.: assets & liabilities
Figure 17: F. Hoffmann-La Roche Ltd: revenues & profitability
Figure 18: F. Hoffmann-La Roche Ltd: assets & liabilities
Figure 19: Global pharmaceuticals, biotechnology & life sciences industry value forecast: $ billion, 2010–15 Skip to top